Mayo Clinic invests in Ratan Tata-backed cancer care platform Karkinos Healthcare

Karkinos Healthcare, a technology-driven oncology focussed healthcare platform on Sunday said that US-based Mayo Clinic has invested for a minority stake in the company

The company didn't disclose the size of the investment. Karkinos said it will deploy the funds for development of innovative healthcare solutions.

Mayo Clinic will also nominate a member on the Board of Karkinos as part of this agreement.

Karkinos has raised funding from marquee investors such Ratan Tata, Venu Srinivasan, Kris Gopalakrishnan, Ronnie Screwvala, Vijay Shekar Sharma, and Bhavish Agarwal among others.

The Tata Group has invested Rs. 110 crore in Karkinos while Rakuten Medical, the global clinical stage biotechnology company, and Reliance Digital Health, a subsidiary of Reliance Industries, hold minority stakes.

Karkinos is pioneering the Distributed Cancer Care Network model in India addressing clinical needs of cancer patients.

The company works with multiple healthcare institutions and professionals in the oncology ecosystem, successfully bringing care closer to patients backed by a robust technology platform.

Karkinos already offers its services in Kothamangalam, Chottanikkara, Thodupuzha, Munnar locations across Ernakulam and Idukki districts in Kerala and is planning to ramp up its operations across India.

The company is also setting up a Cancer Centre in Jawaharlal Nehru Institute of Medical Sciences (JNIMS) premises at Imphal, in partnership with the Government of Manipur.

*This press release is published by VOH team.*